Sonoma Pharmaceuticals, Inc. (29) | Intellectual Property (3)

Browse by Subcategory

License Agreements (3)

Recent Contracts

Exclusive License and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Anlicare International dated January 18, 2022 (Filed With SEC on January 20, 2022)
Exclusive License and Distribution Agreement between the Company and Dyamed Biotech Pte, Ltd., dated November 4, 2021 (Filed With SEC on November 9, 2021)
License, Distribution and Supply Agreement by and between Sonoma Pharmaceuticals, Inc. and Brill International, S.L. dated May 19, 2020 (Filed With SEC on May 26, 2020)